Adequan i.m. is the only FDA-approved PSGAG equine joint prescription available. It is recommended for intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.1
No, there is no generic version of Adequan i.m. Like their brand-name equivalents, generic drugs must be approved by the FDA. Some equine joint supplements and medical devices are named similarly to the active ingredient in Adequan i.m. and claim to achieve similar results, but these products are not equivalent to Adequan i.m. They are not backed by the required scientific testing to be approved by the FDA as a generic drug. As an FDA-approved animal pharmaceutical product, Adequan i.m. has gone through a rigorous scientific approval process and must also be made in a facility that adheres to Good Manufacturing Practices.